Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cocaine
Drug ID BADD_D00514
Description An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.
Indications and Usage For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.
Marketing Status approved; illicit
ATC Code N01BC01; R02AD03; S01HA01; S02DA02
DrugBank ID DB00907
KEGG ID D00110
MeSH ID D003042
PubChem ID 446220
TTD Drug ID D04XPW
NDC Product Code Not Available
UNII I5Y540LHVR
Synonyms Cocaine | Cocaine Hydrochloride | Hydrochloride, Cocaine | Cocaine HCl | HCl, Cocaine
Chemical Information
Molecular Formula C17H21NO4
CAS Registry Number 50-36-2
SMILES CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation17.02.05.012; 19.06.02.001--
Arteriospasm coronary02.02.02.005; 12.02.01.031; 24.04.04.0050.000099%-
Asthma10.01.03.010; 22.03.01.0020.000099%-
Bronchospasm10.01.03.012; 22.03.01.0040.000099%
Cardiac arrest02.03.04.0010.000745%
Chills08.01.09.001; 15.05.03.016--
Completed suicide08.04.01.010; 19.12.01.0010.000745%-
Death08.04.01.001--
Drug abuse19.07.06.0100.000397%-
Drug dependence19.07.06.0110.000099%-
Flushing08.01.03.025; 23.06.05.003; 24.03.01.002--
Generalised tonic-clonic seizure17.12.01.002---
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Leukoencephalopathy17.13.02.003--
Mydriasis06.05.03.004; 17.02.11.003---
Nausea07.01.07.001--
Nervousness19.06.02.003---
Neutropenia01.02.03.004---
Purpura01.01.04.003; 23.06.01.004; 24.07.06.005--
Rash23.03.13.001---
Respiratory arrest22.02.01.0090.000696%-
Respiratory failure14.01.04.003; 22.02.06.002--
Rhabdomyolysis15.05.05.0020.000099%
Seizure17.12.03.001--
Somnolence17.02.04.006; 19.02.05.003--
Suicide attempt19.12.01.0040.000099%
Tension19.06.02.005---
Torsade de pointes02.03.04.0050.000099%-
Tremor17.01.06.002--
The 1th Page    1 2    Next   Last    Total 2 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene